Skip to main content Accessibility help
×
Home

Novel method of intralesional cidofovir injection into laryngotracheal papillomata

  • R S Sahota (a1), F J Uddin (a1), J AL-Shukri (a1) and A A Moir (a1)

Abstract

Laryngeal papillomatosis is characterised by multiple papillomata affecting the upper respiratory tract. This condition is difficult to treat due to its recurrent nature. Treatment often involves surgical debulking. A number of non-surgical treatments have been reported. Intralesional cidofovir, a cytosine nucleoside analogue with antiviral activity, has been used in an attempt to manage the condition. We present a novel technique of administering cidofovir in a case of recurrent laryngotracheal papillomata.

Copyright

Corresponding author

Address for correspondence: Mr R S Sahota, Department of Otorhinolaryngology, Leicester Royal Infirmary, Leicester LE1 5WW, UK E-mail: rss8@le.ac.uk

References

Hide All
1Snoeck, R, Wellens, W, Desloovere, C, Van Ranst, M, Naesens, L, De Clercq, E et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 1998;54:219–25
2Pudszuhn, A, Welzel, C, Bloching, M, Neumann, K. Intralesional cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 2007;264:6370
3Pawlita, M, Gissmann, L. Recurrent respiratory papillomatosis: indication for HPV vaccination? [in German] Dtsch Med Wochenschr 2009;134(suppl 2):100–2
4Shehab, N, Sweet, BV, Hogikyan, ND. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy 2005;25:977–89
5El-Hakim, H, Waddell, AN, Crysdale, WS. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 2002;31:333–5
6Neumann, K, Pudszuhn, A, Welzel, C, Bartel-Friedrich, S, Passmann, M. Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results [in German]. Laryngorhinootologie 2003;82:700–6
7Schraff, S, Derkay, CS, Burke, B, Lawson, L. American Society of Pediatric Otolaryngology members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004;130:1039–42
8Bielamowicz, S, Villagomez, V, Stager, SV, Wilson, WR. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002;112:696–9
9Chung, BJ, Akst, LM, Koltai, PJ. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2006;70:1911–17
10Dikkers, FG. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir – a prospective study. Eur Arch Otorhinolaryngol 2006;263:440–3
11Bielecki, I, Mniszek, J, Cofała, M. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol 2009;73:681–4
12Wemer, RD, Lee, JH, Hoffman, HT, Robinson, RA, Smith, RJ. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114:836–9
13Kimberlin, DW. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Res 2004;63:141–51
14Broekema, FI, Dikkers, FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2008;265:871–9
15Lindsay, F, Bloom, D, Pransky, S, Stabley, R, Shick, P. Histologic review of cidofovir-treated recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2008;117:113–17
16Tanna, N, Sidell, D, Joshi, AS, Bielamowicz, SA. Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective. Arch Otolaryngol Head Neck Surg 2008;134:497500
17 Disposable varices injector by Cook. In: http://www.cookmedical.com/esc/content/mmedia/16386_0106DVI.pdf [January 2010]

Keywords

Novel method of intralesional cidofovir injection into laryngotracheal papillomata

  • R S Sahota (a1), F J Uddin (a1), J AL-Shukri (a1) and A A Moir (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed